Clearmind Medicine Inc (CMND) Business News Nov. 05, 2025, 11:55 UTC Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing Full text
Register to leave comments News bot Nov. 11, 2025, 5:08 p.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical